U.S. MARKETS FOR DRUG AND FLUID DELIVERY DEVICES

180 Pages | 52 Exhibits | 2015 Analysis | Forecasts Through 2019 Product Family: Market Reports




OVERVIEW:
Pharmacotherapy represents the first-line treatment in the management of most chronic and transient medical conditions warranting therapeutic intervention in the U.S. To date, more than 40,000 prescription drug products containing 2,700 active ingredients have been approved by the FDA; these products accounted for more than 70% of the national pharmaceutical usage in 2014. In the same year, U.S. pharmacies processed nearly 4 billion prescriptions, generating more than $310.0 billion in cumulative pharmaceutical sales and representing nearly 13% of the nation's total healthcare spending. This report covers injection/infusion, transdermal, and inhalation drug delivery devices.

This new report by Medtech Insight presents a detailed overview of the U.S. drug and fluid delivery devices market. Major topics covered by this report include an overview of drug delivery technologies, injection/infusion drug delivery systems (e.g., syringes, injection pens, needleless jet injectors, infusion pumps and disposables, gravity infusion systems, and vascular access devices), transdermal drug delivery systems (e.g., patch-based pharmaceutical products for cardiovascular disease management, central nervous system disorder management, hormone replacement therapy, acute and chronic pain management, and urologic disorder management), and inhalation drug delivery systems (e.g., inhaled insulin delivery systems and inhaled respiratory drug systems such as dry powder inhaler- and metered dose inhaler-based preparations for the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis).

TABLE OF CONTENTS:
EXECUTIVE SUMMARY

i. Injection/Infusion Drug Delivery Systems
ii. Transdermal Drug Delivery Systems
iii. Inhalation Drug Delivery Systems
iv. Methodology

Exhibit ES-1: Injection/Infusion Drug Delivery Systems, Market Share, by Product Segment, 2014 and 2019
Exhibit ES-2: Patch-Based Pharmaceutical Products, Market Share, by Product Segment, 2014 and 2019
Exhibit ES-3: Inhalation Drug Delivery Products, Market Share, by Product Segment, 2014 and 2019

1. INJECTION/INFUSION DRUG DELIVERY SYSTEMS

1.1 Products and Technologies
	1.2.1 Syringe Products
		1.2.1.1 Multipurpose Standard Syringes
		1.2.1.2 Multipurpose Safety Syringes
		1.2.1.3 Insulin Syringes
		1.2.1.4 Market Analysis
		1.2.1.5 Competitive Analysis
	1.2.2 Injection Pen Products
		1.2.2.1 Market Analysis
		1.2.2.2 Competitive Analysis
	1.2.3 Needleless Jet Injector Products
		1.2.3.1 Market Analysis
		1.2.3.2 Competitive Analysis
	1.2.4 Infusion Pump Products
		1.2.4.1 Volumetric Pumps
			1.2.4.1.1 Market Analysis
			1.2.4.1.2 Competitive Analysis
		1.2.4.2 Syringe Pumps
			1.2.4.2.1 Market Analysis
			1.2.4.2.2 Competitive Analysis
		1.2.4.3 Ambulatory Pumps
			1.2.4.3.1 Market Analysis
			1.2.4.3.2 Competitive Analysis
		1.2.4.4 Disposable Pumps
			1.2.4.4.1 Market Analysis
			1.2.4.4.2 Competitive Analysis
		1.2.4.5 Implantable Pumps
			1.2.4.5.1 Market Analysis
			1.2.4.5.2 Competitive Analysis
		1.2.4.6 Insulin Pumps
			1.2.4.6.1 Market Analysis
			1.2.4.6.2 Competitive Analysis
		1.2.4.7 Enteral Pumps and Gravity Systems
			1.2.4.7.1 Market Analysis
			1.2.4.7.2 Competitive Analysis
		1.2.4.8 Intravascular Gravity Infusion Systems
			1.2.4.8.1 Market Analysis
			1.2.4.8.2 Competitive Analysis
	1.2.5 Vascular Access Products
		1.2.5.1 Short Peripheral Catheters
			1.2.5.1.1 Market Analysis
			1.2.5.1.2 Competitive Analysis
		1.2.5.2 Midline Catheters
			1.2.5.2.1 Market Analysis
			1.2.5.2.2 Competitive Analysis
		1.2.5.3 Peripherally Inserted Central Catheters
			1.2.5.3.1 Market Analysis
			1.2.5.3.2 Competitive Analysis
		1.2.5.4 Central Venous Catheters
			1.2.5.4.1 Market Analysis
			1.2.5.4.2 Competitive Analysis
		1.2.5.5 Implantable Ports
			1.2.5.5.1 Market Analysis
			1.2.5.5.2 Competitive Analysis

Exhibit 1-1: Injection/Infusion Drug Delivery Systems, Combined Market Forecast, 2014-2019
Exhibit 1-2: Multipurpose and Insulin Syringes, Market Forecast, 2014-2019
Exhibit 1-3: 2014, Multipurpose and Insulin Syringes Market, Share by Supplier
Exhibit 1-4: Insulin Pen Products, Market Forecast, 2014-2019
Exhibit 1-5: 2014, Insulin Pen Products Market, Share by Supplier
Exhibit 1-6: Needleless Jet Injectors, Market Forecast, 2014-2019
Exhibit 1-7: 2014, Needleless Jet Injectors Market, Share by Supplier
Exhibit 1-8: Infusion Pumps, Combined Market Forecast, 2014-2019
Exhibit 1-9: Volumetric Pumps and Disposables, Market Forecast, 2014-2019
Exhibit 1-10: 2014, Volumetric Pumps and Disposables Market, Share by Supplier
Exhibit 1-11: Syringe Pumps and Disposables, Market Forecast, 2014-2019
Exhibit 1-12: 2014, Syringe Pumps and Disposables Market, Share by Supplier
Exhibit 1-13: Ambulatory Pumps, Market Forecast, 2014-2019
Exhibit 1-14: 2014, Ambulatory Pumps and Disposables Market, Share by Supplier
Exhibit 1-15: Disposable Infusion Pumps, Market Forecast, 2014-2019
Exhibit 1-16: 2014, Disposable Infusion Pumps Market, Share by Supplier
Exhibit 1-17: Implantable Infusion Pumps, Market Forecast, 2014-2019
Exhibit 1-18: 2014, Implantable Infusion Pumps Market, Share by Supplier
Exhibit 1-19: Insulin Pumps and Disposables, Market Forecast, 2014-2019
Exhibit 1-20: 2014, Insulin Pumps and Disposables Market, Share by Supplier
Exhibit 1-21: Enteral Pumps, Disposables, and Gravity Sets, Market Forecast, 2014-2019
Exhibit 1-22: 2014, Enteral Pumps, Disposables, and Gravity Sets Market, Share by Supplier
Exhibit 1-23: Intravenous Gravity Infusion Systems, Market Forecast, 2014-2019
Exhibit 1-24: 2014, Intravenous Gravity Infusion Systems Market, Share by Supplier
Exhibit 1-25: Vascular Access Devices, Combined Market Forecast, 2014-2019
Exhibit 1-26: Short Peripheral Catheters, Market Forecast, 2014-2019
Exhibit 1-27: 2014, Short Peripheral Catheters Market, Share by Supplier
Exhibit 1-28: Midline Catheters, Market Forecast, 2014-2019
Exhibit 1-29: 2014, Midline Catheters Market, Share by Supplier
Exhibit 1-30: Peripherally Inserted Central Catheters, Market Forecast, 2014-2019
Exhibit 1-31: 2014, Peripherally Inserted Central Catheters Market, Share by Supplier
Exhibit 1-32: Central Venous Catheters, Market Forecast, 2014-2019
Exhibit 1-33: 2014, Central Venous Catheters Market, Share by Supplier
Exhibit 1-34: Implantable Ports, Market Forecast, 2014-2019
Exhibit 1-35: 2014, Implantable Ports Market, Share by Supplier

2. TRANSDERMAL DRUG DELIVERY SYSTEMS

2.1 Technology
	2.1.1 Passive Transdermal Transport Systems
	2.1.2 Active Transdermal Transport Systems
2.2 Clinical Applications
	2.2.1 Cardiovascular Disease Management
		2.2.1.1 Products
		2.2.1.2 Market Analysis
		2.2.1.3 Competitive Analysis
	2.2.2 Central Nervous System Disorder Management
		2.2.2.1 Products
		2.2.2.2 Market Analysis
		2.2.2.3 Competitive Analysis
	2.2.3 Hormone Replacement Therapy
		2.2.3.1 Products
		2.2.3.2 Market Forecast
		2.2.3.3 Competitive Analysis
	2.2.4 Pain Management
		2.2.4.1 Cancer-Related Pain
		2.2.4.2 Post-Herpetic Neuralgia
		2.2.4.3 Products
		2.2.4.4 Market Analysis
		2.2.4.5 Competitive Analysis
	2.2.5 Urologic Disorder Management
		2.2.5.1 Products
		2.2.5.2 Market Analysis

Exhibit 2-1: Patch-Based Pharmaceutical Products, by Application, Combined Market Forecast, 2014-2019
Exhibit 2-2: Patch-Based Clonidine and Nitroglycerin Products, Market Forecast, 2014-2019
Exhibit 2-3: 2014, Patch-Based Clonidine and Nitroglycerin Products Market, Share by Supplier
Exhibit 2-4: Patch-Based Central Nervous System Disorder Treatment Products, Market Forecast, 2014-2019
Exhibit 2-5: 2014, Patch-Based Central Nervous System Disorder Treatment Products Market, Share by Supplier
Exhibit 2-6: Patch-Based Estrogen Replacement Products, Market Forecast, 2014-2019
Exhibit 2-7: 2014, Patch-Based Estrogen Replacement Products Market, Share by Supplier
Exhibit 2-8: Patch-Based Pain Management Products, Market Forecast, 2014-2019
Exhibit 2-9: 2014, Patch-Based Pain Management Products Market, Share by Supplier
Exhibit 2-10: Patch-Based Urologic Treatment Products, Market Forecast, 2014-2019

3. INHALATION DRUG DELIVERY SYSTEMS

3.1 Chronic Respiratory Disorder Management
	3.1.1 Bronchial Asthma
	3.1.2 Chronic Obstructive Pulmonary Disease
	3.1.3 Cystic Fibrosis
	3.1.4 Obstructive Pulmonary Disorder Management
		3.1.4.1 Allergy-Blocking Agents
		3.1.4.2 Anti-Inflammatory Agents
		3.1.4.3 Bronchodilators
3.2 Diabetes Management
3.3 Emerging Applications
	3.3.1 Alkermes
	3.3.2 Aradigm
	3.3.3 MannKind
	3.3.4 Nektar Therapeutics
3.4 Technology
	3.4.1 Metered Dose Inhalers
		3.4.1.1 Breath-Actuated Metered Dose Inhalers
		3.4.1.2 Chlorofluorocarbon-Free Metered Dose Inhalers
		3.4.1.3 Spacers for Use with Metered Dose Inhalers
	3.4.2 Dry Powder Inhalers
	3.4.3 Nebulizers
3.5 Products
3.6 Market Analysis
3.7 Competitive Analysis

Exhibit 3-1: 2015, Selected Inhalation Therapy Agents
Exhibit 3-2: Advantages and Disadvantages of Inhalation Drug Delivery Devices
Exhibit 3-3: Inhalation Drug Delivery Products, Market Forecast, 2014-2019
Exhibit 3-4: 2014, Inhalation Respiratory Drug Delivery Products Market, Share by Supplier

APPENDIX:  COMPANY LISTING


COMPANIES COVERED:

  1. 3M Health Care/3M
  2. Abbott Laboratories
  3. Acrux LTD
  4. Activa Brand Products, Inc.
  5. Alkermes PLC
  6. Allergan, Inc.
  7. AngioDynamics, Inc.
  8. Animas Corporation/Johnson & Johnson
  9. Antares Pharma, Inc.
  10. Apotex, Inc.
  11. Apricus Biosciences, Inc.
  12. Aradigm Corporation
  13. AstraZeneca PLC
  14. Baxter Healthcare Corporation/ Baxter International, Inc.
  15. Bayer HealthCare/ Bayer AG
  16. BD (Becton, Dickinson and Company)
  17. Bioject Medical Technologies, Inc.
  18. Boehringer Ingelheim GmbH
  19. B. Braun Melsungen AG
  20. CareFusion Corporation/BD
  21. CME America LLC
  22. Codman & Shurtleff, Inc./Johnson & Johnson
  23. Cook Medical/Cook Group, Inc.
  24. CORPAK MedSystems, Inc./ Linden Capital Partners LLC
  25. C.R. Bard, Inc.
  26. Delta Hi-Tech, Inc.
  27. Eli Lilly and Company
  28. Endo Pharmaceuticals Holdings, Inc.
  29. Fennec Pharmaceuticals, Inc.
  30. Forest Laboratories, Inc./ Allergan, Inc.
  31. GlaxoSmithKline PLC
  32. Halyard Health, Inc.
  33. Heron Therapeutics, Inc.
  34. Hospira, Inc./Pfizer, Inc.
  35. Inovio Pharmaceuticals, Inc.
  36. Insulet Corporation
  37. Janssen Pharmaceuticals, Inc./Johnson & Johnson
  38. Johnson & Johnson
  39. Kawasumi Laboratories America, Inc./Kawasumi Laboratories, Inc.
  40. MannKind Corporation
  41. MediCore, Inc.
  42. Medtronic, Inc.
  43. Medtronic, Minimally Invasive Therapies, Inc./Medtronic, Inc.
  44. Merck & Co., Inc.
  45. Moog, Inc.
  46. Mylan Laboratories, Inc.
  47. NanoPass Technologies LTD
  48. National Medical Products, Inc.
  49. Nektar Therapeutics, Inc.
  50. Nestle Group
  51. Novartis AG
  52. Noven Pharmaceuticals, Inc./Hisamitsu Pharmaceutical Co., Inc.
  53. Novo Nordisk A/S
  54. Owen Mumford LTD
  55. PenJet Corporation
  56. PharmaJet, Inc.
  57. QLT, Inc.
  58. Repro-Med Systems, Inc. (dba RMS Medical Products)
  59. Retractable Technologies, Inc.
  60. Robbins Instruments, Inc.
  61. Roche Diagnostics/ F. Hoffman-La Roche LTD
  62. Sandoz/Novartis AG
  63. sanofi-aventis SA
  64. Smiths Medical, Inc./ Smiths Group PLC
  65. Sol-Millennium Medical, Inc./Sol-Millennium Group
  66. Sooil USA/ Sooil Development Co., LTD
  67. Sunovion Pharmaceuticals, Inc./ Sumitomo Dainippon Pharma Co., LTD
  68. Teikoku Pharma, Inc.
  69. Teleflex Medical, Inc./ Teleflex, Inc.
  70. Terumo Medical Corporation/ Terumo Corporation
  71. Teva Pharmaceuticals/ Teva Pharmaceutical Industries LTD
  72. UltiMed, Inc.
  73. U.S. Medical Instruments, Inc.
  74. WalkMed Infusion LLC
  75. Zosano Pharma, Inc.
Contact Us

Need help finding medtech research? Let us help you!